Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11773171 WNT surrogate molecules and uses thereof

Patent 11773171 was granted and assigned to Surrozen on October, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Yang Li

Claudia Yvonne Janda

Tristan William Fowler

Kuo-Pao Lai

Aaron Ken Sato

Tom Zhiye Yuan

Helene Baribault

Chenggang Lu

...

Date of Patent

October 3, 2023

Patent Application Number

16954484

Date Filed

December 19, 2018

Patent Citations

US Patent 7657380 Methods of generating variant antibodies with increased host string content

US Patent 7297775 Polypeptide variants

US Patent 7317091 Optimized Fc variants

US Patent 7364731 Polypeptide variants

US Patent 7662925 Optimized Fc variants and methods for their generation

US Patent 7982013 Frizzled-binding agents and uses thereof

US Patent 8202966 Human Dickkopf-related protein and nucleic acid molecules and uses therefor

US Patent 8221751 Tumor-targeting monoclonal antibodies to FZD10 and uses thereof

...

Patent Primary Examiner

Meera Natarajan

CPC Code

Patent abstract

The present invention provides Wnt pathway agonists and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11773171 WNT surrogate molecules and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.